← SynDRA
TIPELUKAST
SynDRA canonical compound SYN0030953 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ALOX5 | CYSLTR1 | CYSLTR2 | LTB4R | LTB4R2 |
|---|
| Mechanism of action | leukotriene receptor antagonist |
|---|
All known targets
- ALOX5
- CYSLTR1
- CYSLTR2
- LTB4R
- LTB4R2
Mechanisms of action (all sources)
- leukotriene receptor antagonist
- ALOX5 MODULATOR
Cross-references
Synonyms
- KCA-757
- MN-001
- Asthma therapy, MediciNova
- MN001 cpd
- RefChem:190100
- MN 001
- KCA 757
- MN-001 (Tipelukast)
- KCA 757;MN 001
- Tipelukast (USAN)
- TIPELUKAST [USAN]
- KCA757
- Tipelukast [USAN:INN]
- MN 001 (pharmaceutical)
- UNII-08379P260O
- TIPELUKAST [INN]
- TIPELUKAST [MART.]
- TIPELUKAST [WHO-DD]
- SCHEMBL154898
- orb1707142
- SCHEMBL29359070
- C29H38O7S
- CHEBI:177735
- KPWYNAGOBXLMSE-UHFFFAOYSA-N
- AFA96182
- MFCD00886138
- AKOS015914770
- CS-6822
- SB17439
- DA-58594
- HY-14938
- MS-29819
- NS00069211
- D06659
- G12830
- T15647
- L001366
Look up TIPELUKAST in the interactive SynDRA portal →